Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/94690
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFalchook, G.-
dc.contributor.authorLong, G.-
dc.contributor.authorKurzrock, R.-
dc.contributor.authorKim, K.-
dc.contributor.authorArkenau, H.-
dc.contributor.authorBrown, M.-
dc.contributor.authorHamid, O.-
dc.contributor.authorInfante, J.-
dc.contributor.authorMillward, M.-
dc.contributor.authorPavlick, A.-
dc.contributor.authorChin, M.-
dc.contributor.authorO'Day, S.-
dc.contributor.authorBlackman, S.-
dc.contributor.authorCurtis, C.-
dc.contributor.authorLebowitz, P.-
dc.contributor.authorMa, B.-
dc.contributor.authorOuellet, D.-
dc.contributor.authorKefford, R.-
dc.date.issued2014-
dc.identifier.citationClinical Cancer Research, 2014; 20(17):4449-4458-
dc.identifier.issn1557-3265-
dc.identifier.issn1557-3265-
dc.identifier.urihttp://hdl.handle.net/2440/94690-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityGerald S. Falchook, Georgina V. Long, Razelle Kurzrock, Kevin B. Kim, H.-Tobias Arkenau, Michael P. Brown, Omid Hamid, Jeffrey R. Infante, Michael Millward, Anna Pavlick, Melvin T. Chin, Steven J. O'Day, Samuel C. Blackman, C. Martin Curtis, Peter Lebowitz, Bo Ma, Daniele Ouellet, and Richard F. Kefford-
dc.language.isoen-
dc.publisherAmerican Association for Cancer Research-
dc.rights© 2014 American Association for Cancer Research.-
dc.source.urihttp://dx.doi.org/10.1158/1078-0432.ccr-14-0887-
dc.subjectHumans-
dc.subjectMelanoma-
dc.subjectOximes-
dc.subjectImidazoles-
dc.subjectProto-Oncogene Proteins B-raf-
dc.subjectProtein Kinase Inhibitors-
dc.subjectPositron-Emission Tomography-
dc.subjectTreatment Outcome-
dc.subjectDrug Administration Schedule-
dc.subjectDose-Response Relationship, Drug-
dc.subjectMutation-
dc.subjectAdult-
dc.subjectAged-
dc.subjectAged, 80 and over-
dc.subjectMiddle Aged-
dc.subjectFemale-
dc.subjectMale-
dc.titleDose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)-
dc.typeJournal article-
dc.identifier.doi10.1158/1078-0432.CCR-14-0887-
pubs.publication-statusPublished-
dc.identifier.orcidBrown, M. [0000-0002-5796-1932] [0000-0002-6678-1407]-
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.